Our Mission: Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness
UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver
Hygromycin A treatment of Borrelia burgdorferi-infected Peromyscus leucopus suggests potential as a reservoir-targeted antibiotic
✅ Just Accepted
🔗 https://bit.ly/4nC510J
👀The Levy CIMAR has some VERY exciting news to share! 🥳Check out our Laboratory for Combinatorial Drug Regimen Design for Resistant & Emerging Pathogens (LCDRD), a major stride in our mission to fight AMR made possible by a $5.15 million NIH grant. MORE: https://medicine.tufts.edu/news-events/news/new-research-hub-tackle-antimicrobial-resistance
Meet Asli Dirik, a @TuftsUniversity IDoc (interdisciplinary doctoral) student working at @The_SilkLab on advanced bioresponsive materials and wearable interfaces for monitoring vaginal and reproductive health. 1/2 https://www.tuftscimar.org/asli-dirik-tufts-idoc-student-specializing-in-bioresponsive-materials-and-wearable-interfaces-for-monitoring-female-health/
Our Values
The Levy CIMAR is committed to a culture of diversity, equity, and inclusion both within our organization and for all people who are impacted by our work. We strive for health equity for people from all backgrounds and identities, and we actively support societal and institutional structures that promote justice and equality. We are also committed to being a safe, respectful, and inclusive environment for our trainees, staff, faculty, affiliates, and partners. One Health acknowledges the interconnectedness of all humans, along with animals and our environments. Antimicrobial resistance impacts us all.